The global surge in obesity is undeniably contributing to the increasing prevalence of T2DM, a chronic and progressive metabolic disorder characterized by the body’s inability to produce sufficient insulin or to effectively utilize the insulin it produces. The gene discussed is INS; the disease is obesity disorder.